Since studies have indicated AMPs have cellular toxicity or lose antimicrobial activity in the circulation, the prophylactic effect of prescreened AMPs in vivo was examined by intratracheal administration in pneumonia mouse models. This evidence concerns the gene ADSL and susceptibility to pneumonia measurement.